SCHEMBL5208277

SCHEMBL5208277

CCOC(=O)c1cc(O)n(C(C)C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
KMT2A Q03164 2/20 0.41
ADORA3 P0DMS8 2/20 0.41
GAA P10253 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
NR1H2 P55055 2/20 0.40
NR1H3 Q13133 1/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9941672 0.86 CYP1A2 (0.45) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL6734669 0.84 CYP1A2 (0.44) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL21964579 0.83 ADORA3 (0.46) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL21244231 0.83 CYP1A2 (0.42) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL5112015 0.82 MAPK1 (0.39) ADORA3GAACA12CA1CA2
SCHEMBL20094452 0.82 CYP1A2 (0.41) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL22435258 0.82 CYP1A2 (0.41) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL30979681 0.82 KMT2A (0.42) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL22435255 0.81 CYP1A2 (0.41) CYP1A2KMT2AADORA3GAAADORA2A
SCHEMBL537688 0.79 CYP1A2 (0.47) CYP1A2KMT2AADORA3GAACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7241794-B2 Nonnucleoside reverse transcriptase inhibitors ROCHEPALO ALTO LLC (US) 2007-07-10 US disclosed
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed
EP-1401826-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-31 EP disclosed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US disclosed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO disclosed